Log in to save to my catalogue

Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myelopro...

Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myelopro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2686270213

Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers

About this item

Full title

Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers

Publisher

United States: Public Library of Science

Journal title

PloS one, 2022-06, Vol.17 (6), p.e0269960-e0269960

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Peripheral T cell CXCR3 expression has been found uniquely lower in patients having neovascular age-related macular degeneration (nAMD) than in healthy individuals. The CXCR3-axis has been shown to have angiostatic and antifibrotic properties. We have recently investigated systemic markers in patients with myeloproliferative neoplasms (MPNs) becaus...

Alternative Titles

Full title

Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2686270213

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2686270213

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0269960

How to access this item